240 related articles for article (PubMed ID: 23576652)
1. Visceral leishmaniasis with HIV co-infection and cervical lymphadenopathy.
Mishra S; Shukla A; Tripathi AK; Kumar A
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23576652
[TBL] [Abstract][Full Text] [Related]
2. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
[TBL] [Abstract][Full Text] [Related]
3. [Visceral leishmaniasis in patient with HIV infection].
Olea P; Pinilla J
Rev Chilena Infectol; 2013 Apr; 30(2):216-20. PubMed ID: 23677161
[TBL] [Abstract][Full Text] [Related]
4. Visceral leishmaniasis (Kala-azar) in two patients with HIV-1 infection: atypical features and response to therapy.
Hamour AA; Skelly R; Jowitt SN; Wilson GE; Curry A; Wilkins EG; Mandal BK
J Infect; 1998 Mar; 36(2):217-20. PubMed ID: 9570658
[TBL] [Abstract][Full Text] [Related]
5. Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004.
Malik AN; John L; Bruceson AD; Lockwood DN
Emerg Infect Dis; 2006 Aug; 12(8):1257-9. PubMed ID: 16965709
[TBL] [Abstract][Full Text] [Related]
6. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
[TBL] [Abstract][Full Text] [Related]
7. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
[TBL] [Abstract][Full Text] [Related]
8. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
Ali A
Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
[TBL] [Abstract][Full Text] [Related]
9. HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil.
Alexandrino-de-Oliveira P; Santos-Oliveira JR; Dorval ME; Da-Costa Fd; Pereira GR; da Cunha RV; Paniago AM; Da-Cruz AM
Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):692-7. PubMed ID: 20835619
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia.
Hurissa Z; Gebre-Silassie S; Hailu W; Tefera T; Lalloo DG; Cuevas LE; Hailu A
Trop Med Int Health; 2010 Jul; 15(7):848-55. PubMed ID: 20487426
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
Torre-Cisneros J; Villanueva JL; Kindelan JM; Jurado R; Sanchez-Guijo P
Clin Infect Dis; 1993 Oct; 17(4):625-7. PubMed ID: 8268341
[TBL] [Abstract][Full Text] [Related]
12. [Visceral leishmaniasis and HIV infection in the HAART era].
Marques N; Cabral S; Sá R; Coelho F; Oliveira J; Saraiva da Cunha JG; Meliço Silvestre A
Acta Med Port; 2007; 20(4):291-8. PubMed ID: 18198072
[TBL] [Abstract][Full Text] [Related]
13. Relapsing visceral leishmaniasis in a HIV-1 infected patient with advanced disease.
Standaert D; Laurent F; Jonckheere S; Scheiff JM; Vandercam B; Yombi JC
Acta Clin Belg; 2013; 68(2):124-7. PubMed ID: 23967722
[TBL] [Abstract][Full Text] [Related]
14. [The first case of visceral leishmaniasis in a patient with HIV infection in Russia].
Ermak TN; Kravchenko AV; Gruzdev BM; Filippov PG
Ter Arkh; 1997; 69(11):48-50. PubMed ID: 9483748
[TBL] [Abstract][Full Text] [Related]
15. A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure.
Eichenberger A; Buechi AE; Neumayr A; Hatz C; Rauch A; Huguenot M; Diamantis-Karamitopoulou E; Staehelin C
BMC Infect Dis; 2017 Jan; 17(1):81. PubMed ID: 28095796
[TBL] [Abstract][Full Text] [Related]
16. [Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection].
Reus S; Sánchez R; Portilla J; Boix V; Priego M; Merino E; Román F
Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):515-20. PubMed ID: 10650648
[TBL] [Abstract][Full Text] [Related]
17. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB
J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802
[TBL] [Abstract][Full Text] [Related]
18. Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challenge.
Patole S; Burza S; Varghese GM
Int J Infect Dis; 2014 Aug; 25():204-6. PubMed ID: 24927662
[TBL] [Abstract][Full Text] [Related]
19. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection].
Delgado Fernández M; García Ordoñez MA; Martos Pérez F; Reguera Iglesias JM; Jiménez Oñate F; Colmenero Castillo JD
An Med Interna; 1997 Oct; 14(10):506-10. PubMed ID: 9424140
[TBL] [Abstract][Full Text] [Related]
20. Long-term remission of human immunodeficiency virus-associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: report of two cases.
Mastroianni CM; d'Ettorre G; Forcina G; Corpolongo A; Dell'Isola S; Lichtner M; D'Agostino C; Trinchieri V; Santopadre P; Vullo V
J Infect; 2000 Jan; 40(1):94-6. PubMed ID: 10762121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
